Cargando…

Longitudinal Imaging-Based Clusters in Former Smokers of the COPD Cohort Associate with Clinical Characteristics: The SubPopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)

PURPOSE: Quantitative computed tomography (qCT) imaging-based cluster analysis identified clinically meaningful COPD former-smoker subgroups (clusters) based on cross-sectional data. We aimed to identify progression clusters for former smokers using longitudinal data. PATIENTS AND METHODS: We select...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Chunrui, Li, Frank, Choi, Jiwoong, Haghighi, Babak, Choi, Sanghun, Rajaraman, Prathish K, Comellas, Alejandro P, Newell, John D, Lee, Chang Hyun, Barr, R Graham, Bleecker, Eugene, Cooper, Christopher B, Couper, David, Han, Meilan, Hansel, Nadia N, Kanner, Richard E, Kazerooni, Ella A, Kleerup, Eric C, Martinez, Fernando J, O’Neal, Wanda, Paine, Robert, Rennard, Stephen I, Smith, Benjamin M, Woodruff, Prescott G, Hoffman, Eirc A, Lin, Ching-Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178702/
https://www.ncbi.nlm.nih.gov/pubmed/34103907
http://dx.doi.org/10.2147/COPD.S301466
_version_ 1783703629030490112
author Zou, Chunrui
Li, Frank
Choi, Jiwoong
Haghighi, Babak
Choi, Sanghun
Rajaraman, Prathish K
Comellas, Alejandro P
Newell, John D
Lee, Chang Hyun
Barr, R Graham
Bleecker, Eugene
Cooper, Christopher B
Couper, David
Han, Meilan
Hansel, Nadia N
Kanner, Richard E
Kazerooni, Ella A
Kleerup, Eric C
Martinez, Fernando J
O’Neal, Wanda
Paine, Robert
Rennard, Stephen I
Smith, Benjamin M
Woodruff, Prescott G
Hoffman, Eirc A
Lin, Ching-Long
author_facet Zou, Chunrui
Li, Frank
Choi, Jiwoong
Haghighi, Babak
Choi, Sanghun
Rajaraman, Prathish K
Comellas, Alejandro P
Newell, John D
Lee, Chang Hyun
Barr, R Graham
Bleecker, Eugene
Cooper, Christopher B
Couper, David
Han, Meilan
Hansel, Nadia N
Kanner, Richard E
Kazerooni, Ella A
Kleerup, Eric C
Martinez, Fernando J
O’Neal, Wanda
Paine, Robert
Rennard, Stephen I
Smith, Benjamin M
Woodruff, Prescott G
Hoffman, Eirc A
Lin, Ching-Long
author_sort Zou, Chunrui
collection PubMed
description PURPOSE: Quantitative computed tomography (qCT) imaging-based cluster analysis identified clinically meaningful COPD former-smoker subgroups (clusters) based on cross-sectional data. We aimed to identify progression clusters for former smokers using longitudinal data. PATIENTS AND METHODS: We selected 472 former smokers from SPIROMICS with a baseline visit and a one-year follow-up visit. A total of 150 qCT imaging-based variables, comprising 75 variables at baseline and their corresponding progression rates, were derived from the respective inspiration and expiration scans of the two visits. The COPD progression clusters identified were then associated with subject demography, clinical variables and biomarkers. RESULTS: COPD severities at baseline increased with increasing cluster number. Cluster 1 patients were an obese subgroup with rapid progression of functional small airway disease percentage (fSAD%) and emphysema percentage (Emph%). Cluster 2 exhibited a decrease of fSAD% and Emph%, an increase of tissue fraction at total lung capacity and airway narrowing over one year. Cluster 3 showed rapid expansion of Emph% and an attenuation of fSAD%. Cluster 4 demonstrated severe emphysema and fSAD and significant structural alterations at baseline with rapid progression of fSAD% over one year. Subjects with different progression patterns in the same cross-sectional cluster were identified by longitudinal clustering. CONCLUSION: qCT imaging-based metrics at two visits for former smokers allow for the derivation of four statistically stable clusters associated with unique progression patterns and clinical characteristics. Use of baseline variables and their progression rates enables identification of longitudinal clusters, resulting in a refinement of cross-sectional clusters.
format Online
Article
Text
id pubmed-8178702
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-81787022021-06-07 Longitudinal Imaging-Based Clusters in Former Smokers of the COPD Cohort Associate with Clinical Characteristics: The SubPopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS) Zou, Chunrui Li, Frank Choi, Jiwoong Haghighi, Babak Choi, Sanghun Rajaraman, Prathish K Comellas, Alejandro P Newell, John D Lee, Chang Hyun Barr, R Graham Bleecker, Eugene Cooper, Christopher B Couper, David Han, Meilan Hansel, Nadia N Kanner, Richard E Kazerooni, Ella A Kleerup, Eric C Martinez, Fernando J O’Neal, Wanda Paine, Robert Rennard, Stephen I Smith, Benjamin M Woodruff, Prescott G Hoffman, Eirc A Lin, Ching-Long Int J Chron Obstruct Pulmon Dis Original Research PURPOSE: Quantitative computed tomography (qCT) imaging-based cluster analysis identified clinically meaningful COPD former-smoker subgroups (clusters) based on cross-sectional data. We aimed to identify progression clusters for former smokers using longitudinal data. PATIENTS AND METHODS: We selected 472 former smokers from SPIROMICS with a baseline visit and a one-year follow-up visit. A total of 150 qCT imaging-based variables, comprising 75 variables at baseline and their corresponding progression rates, were derived from the respective inspiration and expiration scans of the two visits. The COPD progression clusters identified were then associated with subject demography, clinical variables and biomarkers. RESULTS: COPD severities at baseline increased with increasing cluster number. Cluster 1 patients were an obese subgroup with rapid progression of functional small airway disease percentage (fSAD%) and emphysema percentage (Emph%). Cluster 2 exhibited a decrease of fSAD% and Emph%, an increase of tissue fraction at total lung capacity and airway narrowing over one year. Cluster 3 showed rapid expansion of Emph% and an attenuation of fSAD%. Cluster 4 demonstrated severe emphysema and fSAD and significant structural alterations at baseline with rapid progression of fSAD% over one year. Subjects with different progression patterns in the same cross-sectional cluster were identified by longitudinal clustering. CONCLUSION: qCT imaging-based metrics at two visits for former smokers allow for the derivation of four statistically stable clusters associated with unique progression patterns and clinical characteristics. Use of baseline variables and their progression rates enables identification of longitudinal clusters, resulting in a refinement of cross-sectional clusters. Dove 2021-05-31 /pmc/articles/PMC8178702/ /pubmed/34103907 http://dx.doi.org/10.2147/COPD.S301466 Text en © 2021 Zou et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Zou, Chunrui
Li, Frank
Choi, Jiwoong
Haghighi, Babak
Choi, Sanghun
Rajaraman, Prathish K
Comellas, Alejandro P
Newell, John D
Lee, Chang Hyun
Barr, R Graham
Bleecker, Eugene
Cooper, Christopher B
Couper, David
Han, Meilan
Hansel, Nadia N
Kanner, Richard E
Kazerooni, Ella A
Kleerup, Eric C
Martinez, Fernando J
O’Neal, Wanda
Paine, Robert
Rennard, Stephen I
Smith, Benjamin M
Woodruff, Prescott G
Hoffman, Eirc A
Lin, Ching-Long
Longitudinal Imaging-Based Clusters in Former Smokers of the COPD Cohort Associate with Clinical Characteristics: The SubPopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)
title Longitudinal Imaging-Based Clusters in Former Smokers of the COPD Cohort Associate with Clinical Characteristics: The SubPopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)
title_full Longitudinal Imaging-Based Clusters in Former Smokers of the COPD Cohort Associate with Clinical Characteristics: The SubPopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)
title_fullStr Longitudinal Imaging-Based Clusters in Former Smokers of the COPD Cohort Associate with Clinical Characteristics: The SubPopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)
title_full_unstemmed Longitudinal Imaging-Based Clusters in Former Smokers of the COPD Cohort Associate with Clinical Characteristics: The SubPopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)
title_short Longitudinal Imaging-Based Clusters in Former Smokers of the COPD Cohort Associate with Clinical Characteristics: The SubPopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)
title_sort longitudinal imaging-based clusters in former smokers of the copd cohort associate with clinical characteristics: the subpopulations and intermediate outcome measures in copd study (spiromics)
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178702/
https://www.ncbi.nlm.nih.gov/pubmed/34103907
http://dx.doi.org/10.2147/COPD.S301466
work_keys_str_mv AT zouchunrui longitudinalimagingbasedclustersinformersmokersofthecopdcohortassociatewithclinicalcharacteristicsthesubpopulationsandintermediateoutcomemeasuresincopdstudyspiromics
AT lifrank longitudinalimagingbasedclustersinformersmokersofthecopdcohortassociatewithclinicalcharacteristicsthesubpopulationsandintermediateoutcomemeasuresincopdstudyspiromics
AT choijiwoong longitudinalimagingbasedclustersinformersmokersofthecopdcohortassociatewithclinicalcharacteristicsthesubpopulationsandintermediateoutcomemeasuresincopdstudyspiromics
AT haghighibabak longitudinalimagingbasedclustersinformersmokersofthecopdcohortassociatewithclinicalcharacteristicsthesubpopulationsandintermediateoutcomemeasuresincopdstudyspiromics
AT choisanghun longitudinalimagingbasedclustersinformersmokersofthecopdcohortassociatewithclinicalcharacteristicsthesubpopulationsandintermediateoutcomemeasuresincopdstudyspiromics
AT rajaramanprathishk longitudinalimagingbasedclustersinformersmokersofthecopdcohortassociatewithclinicalcharacteristicsthesubpopulationsandintermediateoutcomemeasuresincopdstudyspiromics
AT comellasalejandrop longitudinalimagingbasedclustersinformersmokersofthecopdcohortassociatewithclinicalcharacteristicsthesubpopulationsandintermediateoutcomemeasuresincopdstudyspiromics
AT newelljohnd longitudinalimagingbasedclustersinformersmokersofthecopdcohortassociatewithclinicalcharacteristicsthesubpopulationsandintermediateoutcomemeasuresincopdstudyspiromics
AT leechanghyun longitudinalimagingbasedclustersinformersmokersofthecopdcohortassociatewithclinicalcharacteristicsthesubpopulationsandintermediateoutcomemeasuresincopdstudyspiromics
AT barrrgraham longitudinalimagingbasedclustersinformersmokersofthecopdcohortassociatewithclinicalcharacteristicsthesubpopulationsandintermediateoutcomemeasuresincopdstudyspiromics
AT bleeckereugene longitudinalimagingbasedclustersinformersmokersofthecopdcohortassociatewithclinicalcharacteristicsthesubpopulationsandintermediateoutcomemeasuresincopdstudyspiromics
AT cooperchristopherb longitudinalimagingbasedclustersinformersmokersofthecopdcohortassociatewithclinicalcharacteristicsthesubpopulationsandintermediateoutcomemeasuresincopdstudyspiromics
AT couperdavid longitudinalimagingbasedclustersinformersmokersofthecopdcohortassociatewithclinicalcharacteristicsthesubpopulationsandintermediateoutcomemeasuresincopdstudyspiromics
AT hanmeilan longitudinalimagingbasedclustersinformersmokersofthecopdcohortassociatewithclinicalcharacteristicsthesubpopulationsandintermediateoutcomemeasuresincopdstudyspiromics
AT hanselnadian longitudinalimagingbasedclustersinformersmokersofthecopdcohortassociatewithclinicalcharacteristicsthesubpopulationsandintermediateoutcomemeasuresincopdstudyspiromics
AT kannerricharde longitudinalimagingbasedclustersinformersmokersofthecopdcohortassociatewithclinicalcharacteristicsthesubpopulationsandintermediateoutcomemeasuresincopdstudyspiromics
AT kazerooniellaa longitudinalimagingbasedclustersinformersmokersofthecopdcohortassociatewithclinicalcharacteristicsthesubpopulationsandintermediateoutcomemeasuresincopdstudyspiromics
AT kleerupericc longitudinalimagingbasedclustersinformersmokersofthecopdcohortassociatewithclinicalcharacteristicsthesubpopulationsandintermediateoutcomemeasuresincopdstudyspiromics
AT martinezfernandoj longitudinalimagingbasedclustersinformersmokersofthecopdcohortassociatewithclinicalcharacteristicsthesubpopulationsandintermediateoutcomemeasuresincopdstudyspiromics
AT onealwanda longitudinalimagingbasedclustersinformersmokersofthecopdcohortassociatewithclinicalcharacteristicsthesubpopulationsandintermediateoutcomemeasuresincopdstudyspiromics
AT painerobert longitudinalimagingbasedclustersinformersmokersofthecopdcohortassociatewithclinicalcharacteristicsthesubpopulationsandintermediateoutcomemeasuresincopdstudyspiromics
AT rennardstepheni longitudinalimagingbasedclustersinformersmokersofthecopdcohortassociatewithclinicalcharacteristicsthesubpopulationsandintermediateoutcomemeasuresincopdstudyspiromics
AT smithbenjaminm longitudinalimagingbasedclustersinformersmokersofthecopdcohortassociatewithclinicalcharacteristicsthesubpopulationsandintermediateoutcomemeasuresincopdstudyspiromics
AT woodruffprescottg longitudinalimagingbasedclustersinformersmokersofthecopdcohortassociatewithclinicalcharacteristicsthesubpopulationsandintermediateoutcomemeasuresincopdstudyspiromics
AT hoffmaneirca longitudinalimagingbasedclustersinformersmokersofthecopdcohortassociatewithclinicalcharacteristicsthesubpopulationsandintermediateoutcomemeasuresincopdstudyspiromics
AT linchinglong longitudinalimagingbasedclustersinformersmokersofthecopdcohortassociatewithclinicalcharacteristicsthesubpopulationsandintermediateoutcomemeasuresincopdstudyspiromics